Octavio Miguel Rivero-Lezcano

Dr. Octavio Miguel Rivero-Lezcano

orcid

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 1995 in Molecular and Cellular Biology
Verified
Journal Article
Open access
PDF file
OROctavio Miguel Rivero-Lezcano
Octavio Miguel Rivero-Lezcano
AMAntonio Marcilla
Antonio Marcilla
JSJeanne H. Sameshima
Jeanne H. Sameshima
KRKeith C. Robbins
Keith C. Robbins
In the second of a series of experiments designed to identify p47nck-Src homology 3 (SH3)-binding molecules, we report the cloning of SAKAP II (Src A box Nck-associated protein II) from an HL60 cDNA expression library. This molecule has been identified as a cDNA encoding the protein product of WASP, which is mutated in Wiskott-Aldrich syndrome patients. Studies in vivo and in vitro demonstrated a highly specific interaction between the SH3 domains of p47nck and Wiskott-Aldrich syndrome protein. Furthermore, anti-Wiskott-Aldrich syndrome protein antibodies recognized a protein of 66 kDa by Western blot (immunoblot) analysis. In vitro translation studies identified the 66-kDa protein as the protein product of WASP, and subcellular fractionation experiments showed that p66WASP is mainly present in the cytosol fraction, although significant amounts are also present in membrane and nuclear fractions. The main p47nck region implicated in the association with p66WASP was found to be the carboxy-terminal SH3 domain.

1 April 1995 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
AMAntonio Marcilla
Antonio Marcilla
OROctavio Miguel Rivero-Lezcano
Octavio Miguel Rivero-Lezcano
AAAlka Agarwal
Alka Agarwal
KRKeith C. Robbins
Keith C. Robbins
We have recently identified the protein product of the c- cbl proto-oncogene as an SH3 binding protein expressed in macrophages. To investigate the possibility that p120is involved in signaling pathways initiated by cell surface receptors for IgG (FcR), lysates of HL60 cells were examined for tyrosine phosphorylation of p120upon FcR engagement. Our findings demonstrate that p120is tyrosine-phosphorylated upon FcR engagement and that this molecule represents the major tyrosine kinase substrate in this signaling pathway. Protein complexes containing p120, p72, and p56 were observed either in resting or activated cells. In vitro studies showed that the direct association between p120and p56 was mediated by the SH3 domain of p56.

1 September 2010 in Clinical and Experimental Immunology
Verified
Journal Article
Open access
PDF file
OROctavio Miguel Rivero-Lezcano
Octavio Miguel Rivero-Lezcano
CGC. González-Cortés
C. González-Cortés
DRD. Reyes-Ruvalcaba
D. Reyes-Ruvalcaba
CDC. Diez-Tascón
C. Diez-Tascón
CCL20 is a chemokine that attracts immature dendritic cells. We show that monocytes, cells characteristic of the innate immune response, infected with Mycobacterium tuberculosis express the CCL20 gene at a much higher level than the same cells infected with non-tuberculous mycobacteria. Interferon (IFN)-γ, a fundamental cytokine in the immune response to tuberculosis, strongly inhibits both the transcription and the translation of CCL20. We have also confirmed that dendritic cells are a suitable host for mycobacteria proliferation, although CCL20 does not seem to influence their intracellular multiplication rate. The chemokine, however, down-regulates the characteristic production of reactive oxygen species (ROS) induced by M. tuberculosis in monocytes, which may affect the activity of the cells. Apoptosis mediated by the mycobacteria, possibly ROS-dependent, was also inhibited by CCL20.

1 January 2019 in International Journal of Mycobacteriology
Verified
Journal Article
Open access
PDF file
OROctavio Miguel Rivero-Lezcano
Octavio Miguel Rivero-Lezcano
CGCarolina González-Cortés
Carolina González-Cortés
MMMehdi Mirsaeidi
Mehdi Mirsaeidi
Epidemiological data show a worldwide increase in nontuberculous mycobacteriosis. Although it has been partially attributed to the improvement of microbiological methodologies that has allowed a better recovery and identification of nontuberculous mycobacteria (NTM), it is generally accepted that there is a genuine incidence augmentation. The reasons of the increase are likely multifactorial, depending on the nature of the pathogen, the host, and their interaction. Mycobacteria from the Mycobacterium tuberculosis complex has been regarded as pathogenic and NTM as opportunistic and nontransmissible. Nevertheless, few differences have been found in either their phenotypic or genotypic characteristics. The phenomenon of M. tuberculosis adaptation to the human host may be taking place again in NTM as a consequence of human environmental alterations that facilitate the interaction with the pathogen. The current worsening of the immunological status of increasing numbers of individuals, a result of factors such as malnutrition (obesity and diabetes), population aging or the widespread use of immunosuppressive medication, may be allowing the rapid evolution and person-to-person transmission of NTM. It is likely that mycobacteriosis incidence will keep escalating. New measures should be taken to deal with these diseases, including their reportability and the implementation of strain genotyping that would shed light on the NTM dissemination routes from the environment or human hosts.

15 June 1995
Verified
Journal Article
Closed access
MKM M Keane
M M Keane
OROctavio Miguel Rivero-Lezcano
Octavio Miguel Rivero-Lezcano
JMJ A Mitchell
J A Mitchell
KRK C Robbins
K C Robbins
SLS Lipkowitz
S Lipkowitz

1 April 2001 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
PDF file
JLJuan Román Luque-Ortega
Juan Román Luque-Ortega
OROctavio Miguel Rivero-Lezcano
Octavio Miguel Rivero-Lezcano
SCSimon L. Croft
Simon L. Croft
LRLuis Rivas
Luis Rivas
A method for the rapid screening of drugs targeting the bioenergetic metabolism ofLeishmaniaspp. was developed. The system is based on the monitoring of changes in the intracellular ATP levels ofLeishmania donovanipromastigotes that occur in vivo, as assessed by the luminescence produced by parasites transfected with a cytoplasmic form ofPhothinus pyralisluciferase and incubated with free-membrane permeabled-luciferin analogued-luciferin–[1-(4,5-dimethoxy-2-nitrophenyl) ethyl ester]. A significant correlation was obtained between the rapid inhibition of luminescence with parasite proliferation and the dissipation of changes in mitochondrial membrane potential (ΔΨm) produced by buparvaquone or plumbagin, two leishmanicidal inhibitors of oxidative phosphorylation. To further validate this test, a screen of 14 standard leishmanicidal drugs, using a 50 μM cutoff, was carried out. Despite its semiquantitative properties and restriction to the promastigote stage, this test compares favorably with other bioenergetic parameters with respect to time and cell number requirements for the screening of drugs that affect mitochondrial activity.